Understanding Vpma Antigenic Variation in Mycoplasma agalactiae
Author Information
Author(s): Chopra-Dewasthaly Rohini, Citti Christine, Glew Michelle D, Zimmermann Martina, Rosengarten Renate, Jechlinger Wolfgang
Primary Institution: University of Veterinary Medicine Vienna
Hypothesis
What is the molecular mechanism behind the high-frequency antigenic variation of Vpma proteins in Mycoplasma agalactiae?
Conclusion
The study shows that the Xer1 recombinase is essential for the phase variation of Vpma proteins in Mycoplasma agalactiae.
Supporting Evidence
- All six Vpma proteins are expressed in the type strain PG2 of Mycoplasma agalactiae.
- Disruption of the xer1 gene leads to a stable expression of a single Vpma protein.
- Complementation of the xer1 gene restores the ability to switch Vpma proteins.
Takeaway
Mycoplasma agalactiae can change its surface proteins to avoid the immune system, and this study found that a specific gene, xer1, is crucial for this process.
Methodology
The researchers used homologous recombination to disrupt the xer1 gene and created phase-locked mutants to study Vpma expression.
Limitations
The study primarily focuses on the role of the xer1 gene and does not explore other potential regulatory factors involved in Vpma variation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website